To the Johns Hopkins Medicine community
Johns Hopkins Medicine faculty members, staff members and students are invited to join Landon King, executive vice dean for the school of medicine, and Robert Califf, commissioner of food and drugs for the Food and Drug Administration (FDA), for a fireside chat about the role of academic medicine in public health. The open forum will be held on Friday, Oct. 28, from 1 to 2 p.m. in Chevy Chase Bank Auditorium at The Johns Hopkins Hospital.
Confirmed as the FDA’s commissioner in February 2016, Dr. Califf is committed to strengthening programs and policies that enable the agency to carry out its mission to protect and promote the public’s health. The fireside chat will culminate his daylong visit with Johns Hopkins Medicine leadership to discuss ways in which Johns Hopkins Medicine, and other academic medical institutions, can assist the FDA in advancing public health through evidence generation, post-market surveillance, strengthening and diversifying the next generation of scientists, and initiatives like precision medicine.
Prior to his current appointment, Dr. Califf served as the FDA’s deputy commissioner for medical products and tobacco, providing executive leadership to the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Tobacco Products. He also oversaw the Office of Special Medical Programs and provided direction for cross-cutting clinical, scientific and regulatory initiatives, including precision medicine, combination products, orphan drugs, pediatric therapeutics and the advisory committee system. Before joining the FDA, Dr. Califf was a professor of medicine and vice chancellor of clinical and translational research at Duke University, and is the founding director of the Duke Clinical Research Institute.
Dr. Califf earned his medical degree from the Duke University School of Medicine. He is a nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health care quality and clinical research. He has led many landmark clinical trials and holds the distinction of being recognized by the Institute for Scientific Information as one of the 10 most cited medical authors, with more than 1,200 peer-reviewed publications.